2026-10-11T22:08:49Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34034773 2026-09-30T17:27:48Z category_8 category_14 category_21 category_46 category_62 category_64 category_106 category_132 category_134 portal_5 item_type_1 month_year_09_2026

<p>Kaplan-Meier analysis of recurrence-free survival after LK.</p> Minghai Huang (9525231) Zhifeng Wu (303016) Dongmei Wei (3836542) Jixiao Nong (25145089) Zhuoyuan Zhang (6628634) Thuthuy Hoang (25145092) Guina Yin (25145095) Microbiology Molecular Biology Biotechnology Immunology Marine Biology Cancer Science Policy Infectious Diseases Virology underwent surgical intervention mooren &# 8217 meier analysis showed final anatomical success failing medical therapy based surgical strategy based surgical algorithm amniotic membrane transplantation although bcva improved aggressive disease biology ulcers &# 8805 primary healing rates higher recurrence risks corrected visual acuity bcva ), recurrence perforations &# 8804 3 stromal thickness amt group compared recurrence rates ulcers involving median recurrence functional acuity xlink "> term follow technical infeasibility sustained immunomodulation severe cases retrospective series penetrating keratoplasty overall 95 nlp ). mean follow local immunosuppression lamellar keratoplasty january 2024 free survival february 2016 clinical outcomes 84 ). 8 %). 36 months 30 months 24 eyes <p>Cumulative probabilities were 71.4%, 63.5%, 32.7%, and 16.3% at 12, 24, 36, and 48 months, respectively. The median recurrence-free survival time was 36 months (95% CI, 25–47 months). LK, lamellar keratoplasty.</p> 2026-09-30T17:27:38Z Image Figure 10.1371/journal.pone.0359413.g004 https://figshare.com/articles/figure/_p_Kaplan-Meier_analysis_of_recurrence-free_survival_after_LK_p_/34034773 CC BY 4.0